doi: 10.1021/jm00096a005.
Determination of the absolute configuration of the active amlodipine enantiomer as (-)-S: a correction
Affiliations
- PMID: 1388206
- DOI: 10.1021/jm00096a005
Item in Clipboard
Determination of the absolute configuration of the active amlodipine enantiomer as (-)-S: a correction
J Med Chem.
.
Abstract
The active (-) enantiomer of amlodipine was originally reported to have R configuration. This does not concur with other 1,4-dihydropyridines with known absolute configuration. This configuration has now been determined by X-ray structural analysis using (1S)-camphanic acid and (S)-2-methoxy-2-phenylethanol as chiral probes. Both determinations gave the S configuration for the amlodipine (-) enantiomer with the greater Ca-antagonistic activity.
Similar articles
-
Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.J Med Chem. 1986 Dec;29(12):2504-11. doi: 10.1021/jm00162a013. J Med Chem. 1986. PMID: 3023614
-
Etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid): a potent antiinflammatory drug. Conformation and absolute configuration of its active enantiomer.J Med Chem. 1986 May;29(5):871-4. doi: 10.1021/jm00155a047. J Med Chem. 1986. PMID: 2939246
-
Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents.J Med Chem. 1992 Aug 21;35(17):3254-63. doi: 10.1021/jm00095a023. J Med Chem. 1992. PMID: 1387168
-
[Amlodipine].Ugeskr Laeger. 1991 Jul 8;153(28):2021-3. Ugeskr Laeger. 1991. PMID: 1830707 Review. Danish. No abstract available.
-
The pharmacokinetic profile of amlodipine.Am Heart J. 1989 Nov;118(5 Pt 2):1100-3. doi: 10.1016/0002-8703(89)90834-x. Am Heart J. 1989. PMID: 2530866 Review.
Cited by
-
Effect of low-dose Levamlodipine Besylate in the treatment of vascular dementia.Sci Rep. 2019 Dec 3;9(1):18248. doi: 10.1038/s41598-019-47868-0. Sci Rep. 2019. PMID: 31796756 Free PMC article.
-
Actions of calcium channel blockers on vascular proteoglycan synthesis: relationship to atherosclerosis.Vasc Health Risk Manag. 2005;1(3):199-208. Vasc Health Risk Manag. 2005. PMID: 17319105 Free PMC article. Review.
-
Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.Eur J Pharmacol. 2011 Nov 16;670(1):105-13. doi: 10.1016/j.ejphar.2011.08.005. Epub 2011 Sep 2. Eur J Pharmacol. 2011. PMID: 21910984 Free PMC article.
-
1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.Pflugers Arch. 2015 Jun;467(6):1237-47. doi: 10.1007/s00424-014-1566-3. Epub 2014 Jul 3. Pflugers Arch. 2015. PMID: 24990197
-
Formulations of Amlodipine: A Review.J Pharm (Cairo). 2016;2016:8961621. doi: 10.1155/2016/8961621. Epub 2016 Oct 16. J Pharm (Cairo). 2016. PMID: 27822402 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources